TLN2 and metastasis: We next analyzed the correlation of the clinical characteristics of GC patients with the expression of lnc-TLN2-4:1 and found that the expression of lnc-TLN2-4:1 is significantly decreased in GC tissue with lymph node metastasis, distant metastasis, or TNM stage I and II compared to that without lymph node metastasis, distant metastasis, or with TNM stage III and IV (Figures 1(c)–1(e)).